PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers
Launched by JOHNS HOPKINS UNIVERSITY · Apr 8, 2019
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PLAN trial is studying how an education and support program can help Korean American elders who may have dementia and their caregivers. Many Korean American seniors face challenges in accessing proper dementia care, so this research aims to provide guidance through trained community health workers. The trial will involve 288 pairs of elders and their caregivers and will compare the benefits of this program with usual care. Researchers want to see if participating in PLAN helps improve the caregivers' understanding of dementia, their confidence in providing care, and overall quality of life for both the elders and their caregivers.
To participate, elders must be Korean American, aged 65 or older, and have some signs of dementia. They also need a caregiver who lives with them or sees them regularly. Caregivers should be at least 18 years old and able to read and speak Korean. Throughout the study, participants can expect to receive helpful resources and support to create a better care plan for dementia. This trial is important because it aims to improve access to dementia care for a community that has been underserved in the past.
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Self-identified as first-generation KA
- • Age 65 years or older
- • CDR 1.0+
- • Has a caregiver who lives in the same household or has at least weekly interactions
- • Able to consent or has a proxy available for consent
- • Written consent to participate in the study
- Caregiver Inclusion Criteria:
- • Age 18 years or older
- • Able to read and speak Korean
- • Lives in the same household with the elder or has at least weekly interactions
- • Written consent to participate in the study and to allow the team to audit medical records for linkage to medical service for dementia
- Patient Exclusion Criteria:
- • Previous diagnosis of dementia
- • All Axis I diagnoses other than depressive disorders (e.g., schizophrenia, bipolar disorder, or substance use disorder)
- • Neurological disorders other than Alzheimer's disease that might affect cognition (e.g., stroke)
- • Use of psychotropic drugs including antipsychotics,
- Caregiver Exclusion Criteria:
- • Plan to move from the area within 6 months
- • Active treatment for a terminal illness or in hospice
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bayside, New York, United States
Annandale, Virginia, United States
Patients applied
Trial Officials
Hae-Ra Han, PhD, RN
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials